The role of patents in an AI driven world
17-18 December 2020
The European Patent Office (EPO) is hosting an online conference about one of the most disruptive fields driving the Fourth Industrial Revolution: artificial intelligence (AI).
AI is ubiquitous today. It is used to recommend online purchases, power virtual assistants, and even for predictive maintenance in smart factories. AI also presents two interesting questions for the patent system. The first asks to what extent AI-related inventions can be protected by patents. The other explores the use of AI by patent offices to improve operational efficiency.
This conference builds on the EPO's acknowledged lead in the patenting of Computer Implemented Inventions (CII), and on the success of our first public AI event, "Patenting Artificial Intelligence" in May 2018. It provides a platform for policymakers, investors, inventors, SMEs, academics, and IP professionals to exchange views and share expertise on AI and IP rights. It also takes into consideration the latest initiatives relating to AI at the level of European institutions.
The Office will provide an update on the latest strategic projects with its IP5 partners and look at the legal aspects and the tools that could influence the work of patent offices worldwide. EPO Chief Economist Yann Ménière will present key findings from the soon to be published study "Patents and the Fourth Industrial Revolution". An additional focus area will be SMEs and their role in fostering a diverse European innovation landscape in the area of AI.
The event programme comprises several online sessions and the event is free of charge. You can choose to attend one, some or all sessions.
Learn more about Digital technologies and their impact on patents:
In view of the present situation with coronavirus (COVID-19) the European Patent Office (EPO) is taking all the necessary preventive measures during this event, and is following the latest health & safety standards and regulations. For further information, please see the latest COVID-19 information.